Kristian Reich Biography and Net Worth

Kristian Reich is the Insider of MoonLake Immunotherapeutics. They are 60 years old.

What is Kristian Reich's net worth?: The estimated net worth of Kristian Reich is at least $56.21 million as of June 17th, 2026. Reich owns 2,824,551 shares of MoonLake Immunotherapeutics stock worth more than $56,208,565 as of June 27th. This net worth approximation does not reflect any other assets that Reich may own. Learn More about Kristian Reich's net worth.
How do I contact Kristian Reich?: The corporate mailing address for Reich and other MoonLake Immunotherapeutics executives is , , . MoonLake Immunotherapeutics can also be reached via phone at 41-41-510-8022 and via email at [email protected]. Learn More on Kristian Reich's contact information.
Has Kristian Reich been buying or selling shares of MoonLake Immunotherapeutics?: During the last quarter, Kristian Reich has sold $1,916,000.00 in shares of MoonLake Immunotherapeutics stock. Most recently, Kristian Reich sold 50,000 shares of the business's stock in a transaction on Wednesday, June 17th. The shares were sold at an average price of $19.43, for a transaction totalling $971,500.00. Following the completion of the sale, the insider now directly owns 2,824,551 shares of the company's stock, valued at $54,881,025.93. Learn More on Kristian Reich's trading history.
Who are MoonLake Immunotherapeutics' active insiders?: MoonLake Immunotherapeutics' insider roster includes Matthias Bodenstedt (CFO), Kristian Reich (Insider), Silva Santos (CEO), and Simon Sturge (Director). Learn More on MoonLake Immunotherapeutics' active insiders.
Are insiders buying or selling shares of MoonLake Immunotherapeutics?: In the last twelve months, insiders at the sold shares 11 times. They sold a total of 10,902,886 shares worth more than $120,481,209.93. The most recent insider tranaction occured on June, 17th when insider Kristian Reich sold 50,000 shares worth more than $971,500.00. Insiders at MoonLake Immunotherapeutics own 12.0% of the company. Learn More about insider trades at MoonLake Immunotherapeutics.
Information on this page was last updated on 6/17/2026.

Kristian Reich Insider Trading History at MoonLake Immunotherapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/17/2026	Sell	50,000	$19.43	$971,500.00	2,824,551
6/15/2026	Sell	50,000	$18.89	$944,500.00	2,924,551
12/9/2025	Sell	72,908	$14.43	$1,052,062.44
12/8/2025	Sell	130,000	$15.08	$1,960,400.00	72,908
2/27/2024	Sell	29,431	$55.00	$1,618,705.00	70,071
2/20/2024	Sell	10,000	$57.43	$574,300.00	100,071
2/16/2024	Sell	10,000	$60.15	$601,500.00	110,071
2/14/2024	Sell	10,000	$62.43	$624,300.00	130,071

Kristian Reich Buying and Selling Activity at MoonLake Immunotherapeutics

MoonLake Immunotherapeutics Company Overview

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.

Today's Range

Now: $19.90

$19.78

$20.34

50 Day Range

MA: $18.17

$16.11

$22.16

2 Week Range

Now: $19.90

$5.95

$62.75

Volume

1,678,260 shs

Average Volume

1,204,677 shs

Market Capitalization

$1.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04